Goff Brian

Goff Brian is listed in filings as Director at Intellia Therapeutics, Inc.. This profile follows SEC Form 4 activity through Apr 6, 2026, including sale activity. Recent filings connect the profile to Intellia Therapeutics, Inc. (NTLA) and Agios Pharmaceuticals, Inc. - Common Stock (AGIO) (AGIO). The current snapshot covers public activity from Jun 17, 2024 to Apr 6, 2026. Reported amounts are shown as $578.8K to $147.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.